Ruikang Medical's installment payment plan is the result of emergency consultation with Yu Cheng and the Medical Insurance Fund.

Although the patient paid the money in installments, Ruikang Medical received the full payment in one lump sum, and the difference in the middle was paid in advance by the medical insurance fund.

In other words, the patient only pays 50,000 yuan down payment, while the medical insurance fund first pays 300,000 yuan on behalf of the patient, and the subsequent installment payment is transferred to the medical insurance fund.

However, because the medical insurance fund itself does not make money from cancer-specific drugs, they should not bear this risk.

Therefore, if there are bad debts and bad debts, they will be compensated by Ruikang Medical and settled once a year. If a patient cannot pay back the money, the uncollected money will be compensated by Ruikang Medical.

As for why the patient is not yet raised and whether to recover, Ruikang Medical will handle it by itself. The medical insurance fund is not responsible. They just help to advance the payment and Ruikang Medical will bear the profit and loss by itself.

The interest generated in the entire installment payment plan is also divided equally by Ruikang Medical and Medical Insurance Fund. Because the medical insurance fund helped advance the money in advance, the interest should also be a share of them.

After all, the financial pressure has been transferred to the medical insurance fund, rather than Ruikang Medical taking the financial pressure.

However, even so, the implementation of installment payments should not lose much. After all, most patients should choose installments that cost more than five years, and the installment interest rate for more than five years is 4.9%.

This interest should roughly be able to fill bad debts and bad debts. Even if it cannot be filled, the gap will not be too big. If you have to die in a year, you will lose 100 million or 200 million US dollars in this regard. For Ruikang Medical today, you can afford it!

Losing $100 million or 200 million a year in exchange for patients who cannot afford to receive treatment to enjoy treatment with cancer drugs, this transaction is profitable!

After all, doing so can also increase the sales of cancer-specific drugs.

As soon as Ruikang Medical's installment payment plan was announced, the sales of cancer-specific drugs surged again. Many patients who could not afford 300,000 yuan in one go all chose to sign installment payment agreements and pay 50,000 yuan first!

After all, this is a life-saving medicine. If you have the opportunity to buy it, you must not give up. Even if the installment payment will generate some interest, it doesn’t matter.

Saving life is more important than that little interest!

If you buy a car or a house, you are willing to pay in installments, so you will naturally be able to afford to prosper your life even more.

Ruikang Medical's installment payments are even bodhisattvas for them. Only Ruikang Medical dares to do this nationwide and even global medical companies.

Other drugs and equipment do not support installment payments at all, and they must be paid in one lump sum!

As soon as this policy was announced, in less than a week, more than one million more patients who purchased cancer-specific drugs across the country, and even hospitals were too busy!

Although many patients have paid for injection and treatment, the hospital cannot receive so many patients for a while. Even if this injection surgery is simple and can be completed in more than ten minutes, it still needs to stay in the hospital for one or two days.

Moreover, many patients also need to cooperate with surgical removal of cancer cells, which is even more troublesome.

There are only more than 30,000 hospitals in the country, and there are only more than 10,000 public hospitals, which still includes the number of second- and third-level hospitals.

At most, one can only treat 100,000 cancer patients every day, and the hospital can only give priority to patients with severe illness.

Many patients can only wait, and the elective surgery is scheduled for one month, and the scheduling is still increasing every day.

For the first time, patients in China enjoyed the efficiency of European and American hospitals. The feeling of scheduling surgery is one or two months later.

Not only the patients and hospitals are in a state of turmoil.

The medical insurance fund was also hit by the impact, because more than one million patients applied for installments at once, and the advance payment amount was more than 300 billion yuan!

Even if the medical insurance fund has a strong foundation and controls ten trillion yuan of funds, 300 billion yuan is not a small amount of money for them. The mobilization between funds is very troublesome and complicated.

Not to mention that the number continues to increase. Every day, new patients continue to apply for installments to purchase cancer-specific drugs.

This made the medical insurance fund a little unbearable, so I could only negotiate with Chen Changan again and delayed the settlement period. The two parties agreed to settle the payment in half a year.

There is no way. If you really need to do instant settlement, the medical insurance department will have to add thousands of accounting possibilities to make it clear.

Chen Changan didn't care about this. Anyway, the cost of producing a cancer-specific drug is only 50,000 yuan. The down payment paid by the patients alone can already pay back. He can continue to invest money in production, and the capital chain is not that tight.

Moreover, the three or four million cancer special medicines sold earlier were all paid in full, and now the money has basically been flowed back to Ruikang Medical's account, and he has invested it in production again. The company's financial situation is still very good.

Now thirteen OEM companies are continuing to produce cancer-specific drugs for Ruikang Medical day and night.

Although the domestic market is not short of stock yet, even if it is short, hospitals cannot perform surgery on more patients. It is scheduled to be a month or two later, and there will be no shortage of drugs in the short term.

However, in the international market, cancer-specific drugs are still in short supply. After more than 4 million cancer-specific drugs prepared by Chen Changan for China, he put the remaining more than 3 million to the international market for sale.

In just three days, these more than three million cancer-specific drugs were sold out by several countries such as Singapore, Malaysia, Thailand, Russia, Brazil, Cuba and other countries.

There are tens of millions of cancer patients around the world, and at least 10 or 20 million patients can afford the treatment costs of 50,000 US dollars.

A mere three million cancer-specific drugs are not enough to meet the international market.

Several major developed countries such as Britain, the United States, France and Germany are urging goods to the local Ruikang Medical Branch every day, requesting that they provide sufficient amounts of cancer-specific drugs to their countries as soon as possible.

But it is useless to urge. As soon as the cancer-specific drugs from OEM companies were produced, they were packaged and sent to Southeast Asia, South America, and countries in the Middle East.

These countries are all on Chen Changan's priority supply list, because starting from artificial hematopoietic equipment and even from Kirin ventilators, these countries have always supported Ruikang Medical's products.

Therefore, Chen Changan naturally repaid his love and gave them the latest cancer special medicines.

As for those developed countries that have blocked the healing agents of cardiomyocytes, wait slowly.

Since they regarded Ruikang Medical as a disaster, they used various excuses to delay and hinder Ruikang Medical's products from the market in their own country.

So don’t beg Ruikang Medical to provide them with special cancer drugs.
Chapter completed!